Fc Receptor–like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue–like Memory B Cells
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Fc receptor–like (FCRL) 5 is a novel IgG binding protein expressed on B cells, with the capacity to regulate Ag receptor signaling. We assessed FCRL5 expression on circulating B cells from healthy donors and found that FCRL5+ cells are most enriched among atypical CD21−/lo/CD27− tissue-like memory (TLM) B cells, which are abnormally expanded in several autoimmune and infectious diseases. Using multicolor flow cytometry, FCRL5+ TLM cells were found to express more CD11c and several inhibitory receptors than did the FCRL5− TLM subset. The homing receptor profiles of the two TLM subsets shared features consistent with migration away from lymphoid tissues, but they also displayed distinct differences. Analysis of IgH V regions in single cells indicated that although both subsets are diverse, the FCRL5+ subset accumulated significantly more somatic mutations. Furthermore, the FCRL5+ subset had more switched isotype expression and more extensive proliferative history. Microarray analysis and quantitative RT-PCR demonstrated that the two TLM subsets possess distinct gene expression profiles, characterized by markedly different CD11c, SOX5, T-bet, and RTN4R expression, as well as differences in expression of inhibitory receptors. Functional analysis revealed that the FCRL5+ TLM subset responds poorly to multiple stimuli compared with the FCRL5− subset, as reflected by reduced calcium mobilization and blunted cell proliferation. We propose that the FCRL5+ TLM subset, but not the FCRL5− TLM subset, underwent Ag-driven development and is severely dysfunctional. The present study elucidates the heterogeneity of TLM B cells and provides the basis to dissect their roles in the pathogenesis of inflammatory and infectious diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It also revealed three CD27+TCL1A− memory B cell populations that expressed the immune sensor AIM2 (ref. 39), including a subset (FCRL5+ memory B cells) that upregulated FCRL5, which encodes a BCR-signaling regulatory protein described to enrich in atypical memory B cells40, and a subset (ITGB1+ memory B cells) that highly expressed proinflammatory genes (S100A4/6/10) and ITGB1, which are involved”
Citations
Cites
Moir, S., Ho, J., Malaspina, A., Wang, W., DiPoto, A. C., O'Shea, M. A., Roby, G., Kottilil, S., Arthos, J., Proschan, M. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072683 · Cited by 901
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Kuehn, H. S., Ouyang, W., Lo, B., Deenick, E. K., Niemela, J. E., Avery, D. T., Schickel, J.-N., Tran, D. Q., Stoddard, J., Zhang, Y., et al. (2014) · Science · doi:10.1126/science.1255904 · Cited by 848
Rubtsov, A. V., Rubtsova, K., Fischer, A., Meehan, R. T., Gillis, J. Z., Kappler, J. W., & Marrack, P. (2011) · Blood · doi:10.1182/blood-2011-01-331462 · Cited by 808 · cited 8×
“Microarray analysis and quantitative RT-PCR demonstrated that the two TLM subsets possess distinct gene expression profiles, characterized by markedly different CD11c, SOX5, T-bet, and RTN4R expression, as well as differences in expression of inhibitory receptors.”
BackgroundInfluentialKurosaki, T., Kometani, K., & Ise, W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3802 · Cited by 691
A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice
Hao, Y., O'Neill, P., Naradikian, M. S., Scholz, J. L., & Cancro, M. P. (2011) · Blood · doi:10.1182/blood-2011-01-330530 · Cited by 622 · cited 6×
“splenic T/B border (43), and uncompromised survival in culture independent of BAFF (41).”
BackgroundInfluentialComplement receptor 2/CD21− human naive B cells contain mostly autoreactive unresponsive clones
Isnardi, I., Ng, Y.-S., Menard, L., Meyers, G., Saadoun, D., Srdanovic, I., Samuels, J., Berman, J., Buckner, J. H., Cunningham-Rundles, C., et al. (2010) · Blood · doi:10.1182/blood-2009-09-243071 · Cited by 477 · cited 6×
“immunodeficiency (CVID Ia) (7, 8), rheumatoid arthritis (8, 9),”
BackgroundResultInfluentialAtypical Memory B Cells Are Greatly Expanded in Individuals Living in a Malaria-Endemic Area
Weiss, G. E., Crompton, P. D., Li, S., Walsh, L. A., Moir, S., Traore, B., Kayentao, K., Ongoiba, A., Doumbo, O. K., & Pierce, S. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901297 · Cited by 470 · cited 3×
“1C), reported on some atypical CD21 memory B cells (2, 5).”
BackgroundResultRecurrent turnover of senescent cells during regeneration of a complex structure
Yun, M. H., Davaapil, H., & Brockes, J. P. (2015) · eLife · doi:10.7554/elife.05505 · Cited by 385
Ehrhardt, G. R. A., Hsu, J. T., Gartland, L., Leu, C.-M., Zhang, S., Davis, R. S., & Cooper, M. D. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050879 · Cited by 345 · cited 2×
“FCRL4 tissue memory B cells described in tonsils constitute another B cell population that shares some of the features of the circulating FCRL5 TLM B cell subset (3, 4).”
BackgroundRakhmanov, M., Keller, B., Gutenberger, S., Foerster, C., Hoenig, M., Driessen, G., van der Burg, M., van Dongen, J. J., Wiech, E., Visentini, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901984106 · Cited by 333
Portugal, S., Tipton, C. M., Sohn, H., Kone, Y., Wang, J., Li, S., Skinner, J., Virtaneva, K., Sturdevant, D. E., Porcella, S. F., et al. (2015) · eLife · doi:10.7554/elife.07218 · Cited by 329 · cited 5×
“However, adults exposed to malaria, who presumably encountered more rounds of malaria infection than did children, display similar SHM rates and replication histories in their TLM and classical memory B cell subsets (12, 40).”
BackgroundResultInfluentialA new CD21low B cell population in the peripheral blood of patients with SLE
Wehr, C., Eibel, H., Masilamani, M., Illges, H., Schlesier, M., Peter, H.-H., & Warnatz, K. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.010 · Cited by 308 · cited 1×
“(5), systemic lupus erythematosus (6), type Ia common variable”
Backgroundvan Zelm, M. C., Szczepański, T., van der Burg, M., & van Dongen, J. J. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20060964 · Cited by 290 · cited 1×
“The assay was performed as published (33).”
CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs
Rubtsov, A. V., Rubtsova, K., Kappler, J. W., Jacobelli, J., Friedman, R. S., & Marrack, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500055 · Cited by 238 · cited 1×
“splenic T/B border (43), and uncompromised survival in culture independent of BAFF (41).”
BackgroundSaadoun, D., Terrier, B., Bannock, J., Vazquez, T., Massad, C., Kang, I., Joly, F., Rosenzwajg, M., Sene, D., Benech, P., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37828 · Cited by 229 · cited 2×
“reduced response to stimuli, and elevated apoptosis (7, 8, 10).”
BackgroundDavis, R. S. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141541 · Cited by 223
Identification of a family of Fc receptor homologs with preferential B cell expression
Davis, R. S., Wang, Y.-H., Kubagawa, H., & Cooper, M. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171308498 · Cited by 217
Charles, E. D., Brunetti, C., Marukian, S., Ritola, K. D., Talal, A. H., Marks, K., Jacobson, I. M., Rice, C. M., & Dustin, L. B. (2011) · Blood · doi:10.1182/blood-2010-10-312942 · Cited by 206
Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies
Muellenbeck, M. F., Ueberheide, B., Amulic, B., Epp, A., Fenyo, D., Busse, C. E., Esen, M., Theisen, M., Mordmüller, B., & Wardemann, H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121970 · Cited by 206 · cited 1×
“However, adults exposed to malaria, who presumably encountered more rounds of malaria infection than did children, display similar SHM rates and replication histories in their TLM and classical memory B cell subsets (12, 40).”
BackgroundDiscriminating gene expression profiles of memory B cell subpopulations
Ehrhardt, G. R. A., Hijikata, A., Kitamura, H., Ohara, O., Wang, J.-Y., & Cooper, M. D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072682 · Cited by 198 · cited 4×
“CD11c forms a dimer with CD18, serving as both complement receptor and adhesion molecule, possibly facilitating Ag uptake and presentation as well as contributing to tissue localization (3, 35).”
BackgroundInfluentialHatzivassiliou, G., Miller, I., Takizawa, J., Palanisamy, N., Rao, P. H., Iida, S., Tagawa, S., Taniwaki, M., Russo, J., Neri, A., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00109-1 · Cited by 193 · cited 1×
“The expression level of FCRL5 is low in peripheral B cells, but it is increased in lymphoid tissues (14, 16).”
BackgroundAge‐associated B cells: key mediators of both protective and autoreactive humoral responses
Naradikian, M. S., Hao, Y., & Cancro, M. P. (2016) · Immunological Reviews · doi:10.1111/imr.12380 · Cited by 153 · cited 8×
“Microarray analysis and quantitative RT-PCR demonstrated that the two TLM subsets possess distinct gene expression profiles, characterized by markedly different CD11c, SOX5, T-bet, and RTN4R expression, as well as differences in expression of inhibitory receptors.”
BackgroundInfluentialFCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure
Sullivan, R. T., Kim, C. C., Fontana, M. F., Feeney, M. E., Jagannathan, P., Boyle, M. J., DRAKELEY, C. J., Ssewanyana, I., Nankya, F., Mayanja‐Kizza, H., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004894 · Cited by 152 · cited 5×
“B cells obtained from children exposed to malaria (36).”
BackgroundResultInfluentialPolson, A. G. (2006) · International Immunology · doi:10.1093/intimm/dxl069 · Cited by 140 · cited 2×
“FCRL5 expression is upregulated in multiple B cells malignancies, including hairy cell leukemia, chronic lymphocytic leukemia, mantle cell lymphoma, and multiple myeloma, but the contribution of FCRL5 to disease manifestation and progression is unclear (16, 26, 27).”
BackgroundCutting Edge: Human FcRL4 and FcRL5 Are Receptors for IgA and IgG
Wilson, T. J., Fuchs, A., & Colonna, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102651 · Cited by 137 · cited 11×
“Potential activating functions were also proposed for FCRL5 (23), similarly to FCRL3 (24) and FCRL4 (25), suggesting dual regulatory capacities.”
BackgroundInfluentialYeo, L., Lom, H., Juarez, M., Snow, M., Buckley, C. D., Filer, A., Raza, K., & Scheel-Toellner, D. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204116 · Cited by 119 · cited 1×
“immunodeficiency (CVID Ia) (7, 8), rheumatoid arthritis (8, 9),”
Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells
Bin Dhuban, K., d’Hennezel, E., Nashi, E., Bar-Or, A., Rieder, S., Shevach, E. M., Nagata, S., & Piccirillo, C. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401803 · Cited by 117
Self-citationTerrier, B., Joly, F., Vazquez, T., Benech, P. D., Rosenzwajg, M., Carpentier, W., Garrido, M., Ghillani‐Dalbin, P., Klatzmann, D., Cacoub, P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102022 · Cited by 113
Sohn, H. W., Krueger, P. D., Davis, R. S., & Pierce, S. K. (2011) · Blood · doi:10.1182/blood-2011-05-353102 · Cited by 109 · cited 10×
“Potential activating functions were also proposed for FCRL5 (23), similarly to FCRL3 (24) and FCRL4 (25), suggesting dual regulatory capacities.”
BackgroundInfluentialVorup‐Jensen, T., Carman, C. V., Shimaoka, M., Schuck, P., Švitel, J., & Springer, T. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409057102 · Cited by 109 · cited 1×
“CD11c forms a dimer with CD18, serving as both complement receptor and adhesion molecule, possibly facilitating Ag uptake and presentation as well as contributing to tissue localization (3, 35).”
BackgroundFc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment
Haga, C. L., Ehrhardt, G. R. A., Boohaker, R. J., Davis, R. S., & Cooper, M. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703354104 · Cited by 107
Swainson, L. A., Mold, J. E., Bajpai, U. D., & McCune, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903943 · Cited by 101
Zhang, L., Zheng, S., Wu, H., Wu, Y., Liu, S., Fan, M., & Zhang, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5040-08.2009 · Cited by 88 · cited 5×
“partners, including BAFF (37), and was shown to be expressed”
BackgroundInfluentialMatesanz-Isabel, J., Sintes, J., Llinàs, L., de Salort, J., Lázaro, A., & Engel, P. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.09.019 · Cited by 86
Kuzmina, Z. J., Krenn, K., Petkov, V., Körmöczi, U., Weigl, R., Rottal, A., Kalhs, P., Mitterbauer, M., Ponhold, L., Dekan, G., et al. (2013) · Blood · doi:10.1182/blood-2012-06-435008 · Cited by 86
Human Fc Receptor–Like 5 Binds Intact IgG via Mechanisms Distinct from Those of Fc Receptors
Franco, A., Damdinsuren, B., Ise, T., Dement-Brown, J., Li, H., Nagata, S., & Tolnay, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202860 · Cited by 85 · cited 1×
“We and others reported that FCRL5 binds intact IgG via a complex mechanism (21, 22), and therefore immune complexes may link FCRL5 to the BCR, potentially blocking B cell activation similarly to the inhibitory FcgRIIB.”
BackgroundSelf-citationFCRL 3 promotes TLR 9‐induced B‐cell activation and suppresses plasma cell differentiation
Li, F. J., Schreeder, D. M., Li, R., Wu, J., & Davis, R. S. (2013) · European Journal of Immunology · doi:10.1002/eji.201243068 · Cited by 84 · cited 5×
“Potential activating functions were also proposed for FCRL5 (23), similarly to FCRL3 (24) and FCRL4 (25), suggesting dual regulatory capacities.”
BackgroundInfluentialFc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T Cells
Nagata, S., Ise, T., & Pastan, I. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802230 · Cited by 74
Self-citationIse, T., Nagata, S., Kreitman, R. J., Wilson, W. H., Wayne, A. S., Stetler‐Stevenson, M., Bishop, M. R., Scheinberg, D., Rassenti, L. Z., Kipps, T. J., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404445 · Cited by 67 · cited 1×
“FCRL5 expression is upregulated in multiple B cells malignancies, including hairy cell leukemia, chronic lymphocytic leukemia, mantle cell lymphoma, and multiple myeloma, but the contribution of FCRL5 to disease manifestation and progression is unclear (16, 26, 27).”
BackgroundSelf-citationDement-Brown, J., Newton, C. S., Ise, T., Damdinsuren, B., Nagata, S., & Tolnay, M. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0211096 · Cited by 66 · cited 2×
“FCRL5 expression itself could be a mark of previous BCR stimulation, as FCRL5 is specifically induced upon BCR stimulation (23).”
BackgroundSelf-citationVidal-Laliena, M., Ros, X. R., March, S., Requena, V., Pétriz, J., & Engel, P. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.08.002 · Cited by 60 · cited 1×
“In flow cytometry analysis, 293T cells transfected with pcDNA3-based expression plasmids encoding FCRL1–5 were incubated with 1 mg/ml FCRL5 F99 or the following reference anti-FCRL1–5 mouse Abs: FCRL1 (clone E3, IgG1), FCRL2 (clone B24, IgG2a), FCRL3 (clone H5, IgG2b), FCRL4 (clone A1, IgG2a), and FCRL5 (clone F56, Ig…”
Ise, T., Maeda, H., Santora, K., Xiang, L., Kreitman, R. J., Pastan, I., & Nagata, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.87.11.1 · Cited by 42
Self-citationZinöcker, S., Schindler, C. E., Skinner, J., Rogosch, T., Waisberg, M., Schickel, J., Meffre, E., Kayentao, K., Ongoïba, A., Traoré, B., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402168 · Cited by 40 · cited 1×
“Intriguingly, we found that FCRL5 TLM B cells from healthy adults displayed significantly lower SHM rate and shorter replication history than did classical memory B cells, similarly to what was reported in children exposed to malaria (45).”
ResultMyelin regulates immune cell adhesion and motility
Pool, M., Niino, M., Rambaldi, I., Robson, K., Bar‐Or, A., & Fournier, A. E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.014 · Cited by 33
Terrier, B., Nagata, S., Ise, T., Rosenzwajg, M., Pastan, I. H., Klatzmann, D., Saadoun, D., & Cacoub, P. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38222 · Cited by 19
Self-citationQuantifiable analysis of human immunoglobulin heavy chain class-switch recombination to all isotypes
Weckert, H. A., Hughes, J. A. I., Benson, E. M., & Dunn, I. S. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00132-5 · Cited by 11 · cited 1×
“cDNA synthesis and PCR were conducted following the published method (32).”
Method
Cited by
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
Su, Y., Chen, D., Yuan, D., Lausted, C., Choi, J., Dai, C. L., Voillet, V., Duvvuri, V. R., Scherler, K., Troisch, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.037 · Cited by 589
“A distinct memory B cell population that has high expression in ITGAX and FCRL5 (Figure 4A), resembling a tissue-likememory B cell phenotype (Li et al., 2016), was found to be high in mild samples compared to healthy samples (Figure 4B).”
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
Wang, S., Wang, J., Kumar, V., Karnell, J. L., Naiman, B., Gross, P. S., Rahman, S., Zerrouki, K., Hanna, R., Morehouse, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03750-7 · Cited by 578
Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Garaud, S., Buisseret, L., Solinas, C., Gu-Trantien, C., de Wind, A., Van den Eynden, G., Naveaux, C., Lodewyckx, J.-N., Boisson, A., Duvillier, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129641 · Cited by 347
“53), and/or (c) a tissue microenvironment favoring immunosuppression as described for BC DCs (54–56).”
Memory B Cells of Mice and Humans
Weisel, F., & Shlomchik, M. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055531 · Cited by 307
Lau, D., Lan, L. Y.-L., Andrews, S. F., Henry, C., Rojas, K. T., Neu, K. E., Huang, M., Huang, Y., DeKosky, B., Palm, A.-K. E., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai8153 · Cited by 269
“Many studies have found direct evidence of this by demonstrating that these subsets have undergone isotype switching (10, 11, 17, 20, 24) and somatic hypermutation (11, 17).”
Background
Metadata
- Authors
- Li, H., Borrego, F., Nagata, S., & Tolnay, M.
- Affiliations
- United States Food and Drug Administration (US)
- Ikerbasque (ES)
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration , Silver Spring, MD 20993
- Corresponding author
- Li, Huifang
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05
- Volume
- 196
- Issue
- 10
- Pages
- 4064-4074
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2340376798
- Cited by
- 81
- References
- 46
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 3 · 2023: 10 · 2022: 13 · 2021: 4 · 2020: 9 · 2019: 8 · 2018: 7 · 2017: 11 · 2016: 2
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Food and Drug Administration
- National Cancer Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- B cell heterogeneity, CD11c, inhibitory receptors, homing receptors, somatic hypermutation, class switch recombination, gene expression profiling, calcium mobilization, B cell dysfunction, autoimmune disease, infectious diseases
- MeSH terms
- Autoimmune Diseases, B-Lymphocytes, Blood Cells, Cell Survival, Cells, Cultured, DNA Mutational Analysis, Gene Expression Regulation, Humans, Immunologic Memory, Infections, Receptors, Antigen, B-Cell, Receptors, Fc, B-Lymphocyte Subsets, Immunoglobulin Class Switching, Calcium Signaling, Tissue Array Analysis, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.